BioSpace News Archive

Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a privately-owned, clinical stage biopharmaceutical company developing medicines for orphan diseases of the kidney, announced today the appointment of Alex Martin as the company’s Chief Executive Officer

UConn Health’s Comprehensive Spine Center is the first in Connecticut to perform tissue repair in herniated disc surgery using innovative technology.

Physicians’ Education Resource®, a worldwide leading resource for continuing medical education, named public health expert and former commissioner of the Food and Drug Administration Scott Gottlieb, M.D., as the keynote speaker for the 37th Annual Chemotherapy Foundation Symposium Innovative Cancer Therapy for Tomorrow®.

K Health, a digital health company that offers free personalized healthcare, and Health Gorilla, a leader in secure interoperability solutions, announced today a collaboration to power new clinical functionality to improve the primary care experience

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), named Children’s Hospital of Richmond at VCU (CHoR) the 26th Certified Duchenne Care Center (CDCC).

Pain and stress management are hot topics in the United States. Like many healthcare providers, Nexus Neurorecovery Center has focused on alternative ways to address discomfort besides medication.

Axxess to Make PlayMaker Health Data Available for More than 2,000 Clients

The BIG3 acknowledges the importance of mental health in achieving overall health. As a professional sports league that presents some of the world’s best athletes competing on a highly visible and public stage, we recognize that encouraging and supporting mental health is not only good for our business but is also a core value of our organization

Eli Lilly Canada Inc. (Lilly Canada) is pleased to announce the availability of VERZENIO™ (abemaciclib). VERZENIO is indicated for the treatment of estrogen and/or progesterone hormone receptor positive (HR+) and human epidermal growth factor 2 negative (HER2-) metastatic breast cancer (

Care Advantage, a leading provider of home healthcare services in the Mid-Atlantic and a BelHealth Investment Partners (“BelHealth”) portfolio company, announced the acquisition of Allegiance Home Care (“Allegiance” or the “Company”).